Trial
NCT01907100
Nintedanib (BIBF 1120) in Mesothelioma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Mesothelioma
Intervention
Nintedanib
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-18